Taking into consideration the recently described role of FcRn in the anti-tumor immune response [18], and the prognostic gene expression signatures that can be derived from tumor-adjacent tissue parts as previously reported for several human malignancies [21, 22], we sought to evaluate the predictive value of FCGRT mRNA expression in non-cancerous tissues obtained from NSCLC patients. Here, FCGRT is linked to non-small cell lung carcinoma.